Alternative Medications for Hypertension When Calcium Channel Blockers Are Not Tolerated
For patients not tolerating Calcium Channel Blockers (CCBs), the recommended alternative first-line medications are Angiotensin Converting Enzyme inhibitors (ACEIs), Angiotensin Receptor Blockers (ARBs), or thiazide/thiazide-like diuretics, depending on patient characteristics. 1
First-Line Alternatives to CCBs
For Non-Black Patients:
- First choice: ACE inhibitors (e.g., lisinopril) or ARBs (e.g., losartan) 1, 2, 3
- Second choice: Thiazide/thiazide-like diuretics (preferably chlorthalidone over hydrochlorothiazide) 1
For Black Patients:
Selection Algorithm Based on Comorbidities
Patients with diabetes or chronic kidney disease:
Patients with heart failure:
Patients with coronary artery disease:
- Beta-blockers and RAS blockers (ACEIs/ARBs) are first-line options 1
Elderly patients (>80 years) or frail patients:
Combination Therapy Approach
If blood pressure remains uncontrolled on monotherapy:
Two-drug combinations:
Three-drug combinations (for resistant hypertension):
Important Considerations
- Avoid combining ACE inhibitors with ARBs as this increases adverse effects without additional benefit 1
- Monitor renal function and electrolytes when starting ACE inhibitors, ARBs, or diuretics 1
- For resistant hypertension (uncontrolled on 3 drugs including a diuretic), consider adding spironolactone, doxazosin, eplerenone, clonidine, or beta-blocker 1, 5
Common Pitfalls to Avoid
- Rapid dose escalation in elderly patients - start at lower doses and titrate gradually 4
- Excessive BP lowering - avoid diastolic BP below 70-75 mmHg in elderly patients with coronary heart disease 4
- Ignoring race-based differences in medication response - black patients generally respond better to diuretics and CCBs than to ACEIs 1
- Overlooking medication adherence - simplify regimens with once-daily dosing and single-pill combinations when possible 1, 4
By following this structured approach to selecting alternative antihypertensive medications when CCBs are not tolerated, clinicians can effectively manage hypertension while minimizing adverse effects and optimizing outcomes for their patients.